Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 1
1988 2
1989 5
1990 3
1991 5
1992 5
1993 6
1994 5
1995 10
1996 12
1997 17
1998 14
1999 6
2000 22
2001 6
2002 19
2003 9
2004 13
2005 12
2006 3
2007 11
2008 14
2009 12
2010 10
2011 9
2012 11
2013 13
2014 19
2015 17
2016 11
2017 12
2018 8
2019 9
2020 12
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

329 results
Results by year
Filters applied: . Clear all
Page 1
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y, Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C. Smith M, et al. Among authors: kakehi y. Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6. Lancet Oncol. 2019. PMID: 30738780 Clinical Trial.
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).
Yokomizo A, Wakabayashi M, Satoh T, Hashine K, Inoue T, Fujimoto K, Egawa S, Habuchi T, Kawashima K, Ishizuka O, Shinohara N, Sugimoto M, Yoshino Y, Nihei K, Fukuda H, Tobisu KI, Kakehi Y, Naito S; JCOG0401 Investigators. Yokomizo A, et al. Among authors: kakehi y. Eur Urol. 2020 Jun;77(6):689-698. doi: 10.1016/j.eururo.2019.11.023. Epub 2019 Dec 19. Eur Urol. 2020. PMID: 31866092 Clinical Trial.
A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.
Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Kakehi Y. Matsubara N, et al. Among authors: kakehi y. Int J Clin Oncol. 2020 Apr;25(4):720-731. doi: 10.1007/s10147-019-01589-6. Epub 2019 Dec 10. Int J Clin Oncol. 2020. PMID: 31823152 Clinical Trial.
Basic research.
Debruyne F, Yoshida O, Olsson C, Bauer J, Höltl W, Kakehi Y, Schalken JA, Borkowsky A. Debruyne F, et al. Among authors: kakehi y. Int J Urol. 1995 Jun;2 Suppl 2:117-21. doi: 10.1111/j.1442-2042.1995.tb00485.x. Int J Urol. 1995. PMID: 7553301 Free article. Review.
[Testicular cancer].
Yoshida O, Kakehi Y. Yoshida O, et al. Among authors: kakehi y. Nihon Hinyokika Gakkai Zasshi. 1989 Dec;80(12):1695-705. doi: 10.5980/jpnjurol1989.80.1695. Nihon Hinyokika Gakkai Zasshi. 1989. PMID: 2696804 Free article. Review. Japanese.
329 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page